Correlation of point-of-care ecarin clotting time versus activated clotting time with Bivalirudin concentrations

被引：27

作者：

Cho, L

Kottke-Marchant, K

Lincoff, AM

Roffi, M

Reginelli, JP

Kaldus, T

Moliterno, DJ

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

[2] Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA

[3] Loyola Univ, Ctr Med, Dept Cardiol, Maywood, IL USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 91卷 / 09期

关键词：

D O I：

10.1016/S0002-9149(03)00159-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1110 / 1113

页数：4

共 12 条

[1] TREATMENT WITH BIVALIRUDIN (HIRULOG) AS COMPARED WITH HEPARIN DURING CORONARY ANGIOPLASTY FOR UNSTABLE OR POSTINFARCTION ANGINA
BITTL, JA
STRONY, J
BRINKER, JA
AHMED, WH
MECKEL, CR
CHAITMAN, BR
MARAGANORE, J
DEUTSCH, E
ADELMAN, B
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) : 764 - 769
[2] Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study
Bittl, JA
Chaitman, BR
Feit, F
Kimball, W
Topol, EJ
[J]. AMERICAN HEART JOURNAL, 2001, 142 (06) : 952 - 959
[3] EVALUATION OF TESTS USED TO MONITOR HEPARIN THERAPY DURING EXTRACORPOREAL-CIRCULATION
BULL, MH
HUSE, WM
BULL, BS
[J]. ANESTHESIOLOGY, 1975, 43 (03) : 346 - 353
[4] Granger CB, 2001, ACUTE CORONARY SYNDROMES, SECOND EDITION, P541
[5] Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)
Lincoff, AM
Kleiman, NS
Kottke-Marchant, K
Maierson, ES
Maresh, K
Wolski, KE
Topol, EJ
[J]. AMERICAN HEART JOURNAL, 2002, 143 (05) : 847 - 853
[6] LINDHOFFLAST E, GESELLSCHAFT THROMBO
[7] A NOVEL WHOLE-BLOOD CAPILLARY TECHNIQUE FOR MEASURING THE PROTHROMBIN TIME
LUCAS, FV
DUNCAN, A
JAY, R
COLEMAN, R
CRAFT, P
CHAN, B
WINFREY, L
MUNGALL, DR
HIRSH, J
[J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (04) : 442 - 446
[8] Ecarin clotting time but not aPTT correlates with PEG-Hirudin plasma activity
Moser, M
Ruef, J
Peter, K
Kohler, B
Gulba, DC
Paterna, N
Nordt, T
Kübler, W
Bode, C
[J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2001, 12 (02) : 165 - 169
[9] Quantitative determination of hirudin in blood and body fluids
Nowak, G
Bucha, E
[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (02) : 197 - 202
[10] Clinical monitoring of hirudin and direct thrombin inhibitors
Nowak, G
[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (05) : 537 - 541

← 1 2 →